Profile data is unavailable for this security.
About the company
Perpetua Medical AB (publ), formerly Pharmacolog I Uppsala AB (publ), is a Sweden-based medical technology company that develops systems and solutions which aim to optimize and ensure correct and effective treatment with injectable drugs. The Company provides solutions and products that verifies that drugs and narcotics used in surgery have not been tampered with, its solutions make a vital contribution to preventing drug diversion. Its products Pharmacolog Dashboard offers a variety of valuable tools, generating reports and statistical analyses of validated pharmaceuticals. Another product WasteLog is a device that manages the workflow by instantly analyzing the waste and returns of injectable controlled substances.
- Revenue in SEK (TTM)13.57m
- Net income in SEK3.96m
- Incorporated2007
- Employees11.00
- LocationPerpetua Medical AB (publ)Knivstagatan 8UPPSALA 753 23SwedenSWE
- Phone+46 18500101
- Websitehttps://perpetuamedical.se/
More ▼
Mergers & acquisitions
| Acquired company | PERP B:STO since announced | Transaction value |
|---|---|---|
| Spirotronic AB | -5.66% | -- |
| Spirotronic AB | -5.66% | 705.00k |
Data delayed at least 15 minutes, as of Feb 06 2026 17:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S2Medical AB (publ) | 18.87m | -996.45k | 11.05m | 17.00 | -- | 0.55 | 31.62 | 0.5858 | -0.0012 | -0.0012 | 0.0224 | 0.0224 | 0.8658 | 0.516 | 12.92 | -- | -4.57 | -56.60 | -6.87 | -104.62 | 95.30 | 69.19 | -5.28 | -138.46 | 0.5176 | -39.17 | 0.00 | -- | 110.53 | 36.49 | 121.19 | -- | -- | -- |
| Inhalation Sciences Sweden AB | 3.24m | -9.93m | 12.14m | 6.00 | -- | 1.23 | -- | 3.75 | -0.4092 | -0.4092 | 0.1154 | 0.2529 | 0.2597 | 0.1161 | 3.10 | 539,666.70 | -79.64 | -30.98 | -98.54 | -45.83 | 89.22 | 75.78 | -306.67 | -47.68 | 4.70 | -521.63 | 0.003 | -- | -36.89 | 4.30 | -8.49 | -- | -- | -- |
| Level Bio AB (publ) | 30.39m | -3.81m | 18.77m | 10.00 | -- | 11.70 | -- | 0.6175 | -0.0591 | -0.0591 | 0.4585 | 0.0253 | 2.14 | 5.39 | 6.09 | 2,762,668.00 | -26.91 | -12.66 | -90.94 | -20.48 | 31.86 | -- | -12.55 | -8.37 | 0.6469 | -46.81 | 0.22 | -- | -3.83 | 7.86 | 16.92 | -- | -- | -- |
| VibroSense Dynamics AB | 2.00m | -4.75m | 26.53m | -- | -- | 2.97 | -- | 13.26 | -0.1611 | -0.1611 | 0.0675 | 0.2727 | 0.1634 | -0.6475 | 10.10 | -- | -38.77 | -49.73 | -45.60 | -58.13 | 128.95 | 98.07 | -237.28 | -389.04 | 4.85 | -- | 0.00 | -- | 3.00 | 12.37 | 36.76 | -- | -2.92 | -- |
| SensoDetect AB | 1.31m | -9.49m | 28.74m | 2.00 | -- | 1.78 | -- | 21.87 | -0.0249 | -0.0249 | 0.0033 | 0.0366 | 0.0944 | -11.78 | 1,314.00 | 657,000.00 | -68.15 | -- | -79.20 | -- | 160.50 | -- | -722.22 | -- | 2.60 | -315.33 | 0.00 | -- | 375.00 | -- | -17.81 | -- | -- | -- |
| Invent Medic Sweden AB | 7.70m | -6.55m | 29.08m | 7.00 | -- | 4.48 | -- | 3.78 | -0.0574 | -0.0574 | 0.0677 | 0.0587 | 0.757 | 2.96 | 4.25 | 962,928.80 | -64.32 | -93.16 | -140.86 | -121.28 | 77.71 | 77.38 | -84.97 | -305.62 | 1.07 | -4.70 | 0.1265 | -- | 9.51 | 63.94 | 10.32 | -- | -7.72 | -- |
| Qlife Holding AB | 290.00k | -6.28m | 32.14m | 5.00 | -- | -- | -- | 110.84 | -0.4088 | -3.03 | 0.0351 | -0.336 | 0.023 | 5.09 | 30.53 | 290,000.00 | -49.72 | -61.64 | -103.82 | -89.60 | -4,222.41 | -36.54 | -2,166.55 | -444.40 | 0.5089 | -- | 2.61 | -- | -79.51 | -- | 76.60 | -- | -- | -- |
| Codelab Capital AS | -92.34bn | -92.34bn | 33.64m | 28.00 | -- | 1.12 | -- | -- | -- | -- | -- | 2.25 | -- | -- | -- | -- | -- | -10.24 | -- | -11.34 | -- | 83.77 | -- | -64.81 | -- | -- | 0.00 | -- | -99.58 | -70.67 | -602.25 | -- | -22.77 | -- |
| Perpetua Medical AB (publ) | 13.57m | 3.96m | 34.23m | 11.00 | 4.57 | 4.58 | 6.32 | 2.52 | 0.8754 | 0.8754 | 3.00 | 0.8731 | 0.4046 | 13.04 | 3.87 | 4,522,697.00 | 11.65 | -71.55 | 19.36 | -91.64 | 4.34 | -49.08 | 28.80 | -180.67 | 2.28 | 8.72 | 0.4216 | -- | -30.16 | 26.04 | 86.47 | -- | -32.00 | -- |
| Miris Holding AB (publ) | 19.52m | -3.93m | 42.50m | 9.00 | -- | 1.97 | -- | 2.18 | -8.82 | -8.82 | 34.34 | 16.18 | 0.7033 | 1.00 | 4.79 | 1,952,100.00 | -14.15 | -49.33 | -20.65 | -97.47 | 85.03 | 90.68 | -20.12 | -74.98 | 2.20 | -3.02 | 0.00 | -- | 13.56 | 8.35 | 53.96 | -- | 8.55 | -- |
Data as of Feb 06 2026. Currency figures normalised to Perpetua Medical AB (publ)'s reporting currency: Swedish Krona SEK
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 31 Mar 2025 | 332.00 | 0.01% |
Data from 30 Dec 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
